The UK-wide trial will test several drugs at the same time, including medicines already used to treat diabetes and ADHD.
Researchers say this could help them find effective treatments faster than traditional studies.
They aim to recruit 1,200 people with Alzheimer’s, with the first drugs expected to finish testing in 2030.
